Cargando…
NAP1L1 Functions as a Novel Prognostic Biomarker Associated With Macrophages and Promotes Tumor Progression by Influencing the Wnt/β-Catenin Pathway in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is regarded as one of the universal cancers in the world. Therefore, our study is based on clinical, molecular mechanism and immunological perspectives to analyze how NAP1L1 affects the progression of HCC. To begin with, the gene expression datasets and clinical data o...
Autores principales: | Shen, Bingbing, Zhu, Wenjie, Liu, Xinyuan, Jiang, Jianxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161088/ https://www.ncbi.nlm.nih.gov/pubmed/35664324 http://dx.doi.org/10.3389/fgene.2022.876253 |
Ejemplares similares
-
MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
por: Zhou, Lei, et al.
Publicado: (2022) -
A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022) -
Epigenetic Regulation of the Wnt/β-Catenin Signaling Pathway in Cancer
por: Sharma, Ankita, et al.
Publicado: (2021) -
Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022) -
DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling
por: Liu, Yu, et al.
Publicado: (2015)